These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3277766)

  • 21. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
    [No Abstract]   [Full Text] [Related]  

  • 23. Present-day possibilities of diagnosis and treatment of chronic liver diseases. Contributions of the research work in the "N. Gh. Lupu" Institute of Internal Medicine.
    Tănăsescu C; Miron C; Pappo A
    Med Interne; 1990; 28(1):3-12. PubMed ID: 2284563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis B viral markers in the liver tissue of HBs-antigen carriers].
    Mansurov KhKh; Mirodzhov GK; Tkalicheva LI
    Arkh Patol; 1984; 46(4):46-51. PubMed ID: 6375639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum hepatitis (hepatitis B): a major challenge to workers in infectious and iatrogenic disease.
    Can Med Assoc J; 1974 Apr; 110(8):974-7 passim. PubMed ID: 4824970
    [No Abstract]   [Full Text] [Related]  

  • 26. Determinants of disease activity and evolution of chronic hepatitis type B.
    Realdi G; Fattovich G; Noventa F; Boscaro S; Alberti A
    Ann Ist Super Sanita; 1987; 24(2):211-5. PubMed ID: 3331067
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
    Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
    Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis.
    Colucci G; Colombo M; Del Ninno E; Paronetto F
    Gastroenterology; 1983 Nov; 85(5):1138-45. PubMed ID: 6225691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic type B hepatitis: clinical course.
    Hoofnagle JH; Davis GL; Hanson RG
    Prog Clin Biol Res; 1983; 143():41-53. PubMed ID: 6669585
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for chronic hepatitis B in Asian males.
    Jacobs JM; Martin P; Munoz SJ; Westerberg S; Hann HW; Moritz MJ; Rubin R; Yang S; Radomski J; Jarrell BE
    Transplant Proc; 1993 Apr; 25(2):1904-6. PubMed ID: 8470221
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tissue markers of hepatitis B virus: useful indicators in the etiologic diagnosis of chronic alcoholic and non-alcoholic liver disease].
    Cuccurullo L; Rambaldi M; Iaquinto G; Ferraraccio F; Ambrosone L; Giardullo N; De Vita A
    Recenti Prog Med; 1986 Sep; 77(9):397-400. PubMed ID: 3797789
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis.
    Govindarajan S; Kanel GC; Peters RL
    Gastroenterology; 1983 Jul; 85(1):160-2. PubMed ID: 6852449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral hepatitis.
    Alcoff J
    J Fam Pract; 1982 Jul; 15(1):141, 145-7, 151-4 in passim. PubMed ID: 6806432
    [No Abstract]   [Full Text] [Related]  

  • 35. Detection of delta, core and surface antigens in the liver of chronic HBsAg carriers.
    Picciotto A; Bastardini R; Boscarino S; Lapertosa G; Mansi C; Savarino V; Celle G
    Pathologica; 1983; 75(1035):121-5. PubMed ID: 6348677
    [No Abstract]   [Full Text] [Related]  

  • 36. [The use of an immunofluorescence technic in the control of chronic HBV hepatitis].
    Ciravegna B; Navone C; Calzia R; Giovale M; Zauli C; Piscopo R
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1037-42. PubMed ID: 6753875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Viral hepatitis in drug-addicts: anatomo-clinical correlations].
    Camarri E; Corsini P; Marchettini G; Almi P; de' Santi MM; del Vecchio MT; Leoncini L; Cintorino M; Luzi P; Tosi P
    Clin Ter; 1984 Aug; 110(4):311-26. PubMed ID: 6237867
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
    Yap SF
    Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic delta hepatitis: a difficult problem for the hepatologist.
    Picciotto A; Celle G
    Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison between immunofluorescent aspects of chronic HBsAG+, HBAG-hepatitis and some cases of chronic toxic-dismetabolic liver diseases].
    Calzia R; Navone C; Bonura L; Massacane R; Piscopo R; Santoni O
    Boll Soc Ital Biol Sper; 1983 Aug; 59(8):1165-71. PubMed ID: 6354212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.